Disease duration and Medsger's severity score are associated with significant liver fibrosis in patients with systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 33, Issue , 2015, Pages 68-74

  Lee, Sang Won ^a   Kim, Beom Kyung ^a,b   Park, Jun Yong ^a,b   Kim, Do Young ^a,b   Ahn, Sang Hoon ^a,b   Song, Jason Jungsik ^a   Park, Yong Beom ^a   Lee, Soo Kon ^a   Han, Kwang Hyub ^a,b   Kim, Seung Up ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Centre   (South Korea)

Author keywords

Liver fibrosis; Liver stiffness; Systemic sclerosis; Transient elastography

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; PENICILLAMINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DRUG TOXICITY; ECHOGRAPHY; ELASTOGRAPHY; FEMALE; HUMAN; LABORATORY TEST; LIVER FIBROSIS; LIVER STIFFNESS; MALE; MEDSGER SEVERITY SCORE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RIGIDITY; SCORING SYSTEM; SYSTEMIC SCLEROSIS; VIRUS INFECTION; CHI SQUARE DISTRIBUTION; HEALTH STATUS; HEALTH STATUS INDICATOR; LIVER CIRRHOSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROGNOSIS; RISK; RISK FACTOR; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SOUTH KOREA; STATISTICAL MODEL;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; REPUBLIC OF KOREA; RISK FACTORS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 84946234202     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. WOLLHEIM FA: Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford) 2005; 44: 1212-6.
2. HERZOG EL, MATHUR A, TAGER AM, FEGHALI-BOSTWICK C, SCHNEIDER F, VARGA J: Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? Arthritis Rheum 2014; 66: 1967-78.
3. DE SANTIS M, CROTTI C, SELMI C: Liver abnormalities in connective tissue diseases. Best Pract Res ClinGastroenterol 2013; 27: 543-51.
4. EFE C, OZASLAN E, NASIROGLU N, TUNCA H, PURNAK T, ALTIPARMAK E: The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature. Dig Dis Sci 2010; 55: 2417-21.
5. CAVAZZANA I, CERIBELLI A, TARABORELLI M et al.: Primary biliary cirrhosis-related autoantibodies in a large cohort of Italian patients with systemic sclerosis. J Rheumatol 2011; 38: 2180-5.
6. ASSASSI S, FRITZLER MJ, ARNETT FC et al.: Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 2009; 36: 2250-6.
7. D'ANGELO WA, FRIES JF, MASI AT, SHULMAN LE: Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46: 428-40.
8. HO YY, LAGARES D, TAGER AM, KAPOOR M: Fibrosis-a lethal component of systemic sclerosis. Nat Rev Rheumatol 2014; 10: 390-402.
9. ABIGNANO G, CUOMO G, BUCH MH et al.: The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis. Ann Rheum Dis 2014; 73: 420-7.
10. TARANTINO G, SPANO A, LOI G et al.: Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis? World J Gastroenterol 2011; 17: 1606-13.
11. LEE SW, PARK HJ, KIM BK et al.: Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate. Arthritis Res Ther 2012; 14: R232.
12. KIM SU, CHOI GH, HAN WK et al.: What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int 2010; 30: 268-74.
13. Preliminary criteria for the classification of systemic sclerosis (scleroderma): Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-90.
14. van den HOOGEN F, KHANNA D, FRANSEN J et al.: 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Ann Rheum Dis 2013; 72: 1747-55.
15. FURST DE, CLEMENTS PJ, STEEN VD et al.: The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 1998; 25: 84-8.
16. MEDSGER TA JR, BOMBARDIERI S, CZIRJAK L, SCORZA R, DELLA ROSSA A, BENCIVELLI W: Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003: 21 (Suppl. 29): S42-6.
17. SANDRIN L, FOURQUET B, HASQUENOPH JM et al.: Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13.
18. CASTERA L, FORNS X, ALBERTI A: Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-47.
19. SASSO M, BEAUGRAND M, DE LEDINGHEN V et al.: Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010; 36: 1825-35.
20. FRIEDRICH-RUST M, ONG MF, MARTENS S et al.: Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-74.
21. KIM KM, CHOI WB, PARK SH et al.: Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol 2007; 42: 382-8.
22. ALLANORE Y, AVOUAC J, KAHAN A: Systemic sclerosis: an update in 2008. Joint Bone Spine 2008; 75: 650-5.
23. CASTERA L: Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol 2011; 25: 291-303.
24. FRASER JR, GIBSON PR: Mechanisms by which food intake elevates circulating levels of hyaluronan in humans. J Intern Med 2005; 258: 460-6.
25. PITON A, POYNARD T, IMBERT-BISMUT F et al.: Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology 1998; 27: 1213-9.